|
ARFGEF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.56100000037185E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.34630000037106E-07 |
| Normal-vs-Stage2 |
2.771900E-02 |
| Normal-vs-Stage3 |
6.763900E-04 |
| Normal-vs-Stage4 |
3.767000E-01 |
| Stage1-vs-Stage2 |
3.381400E-01 |
| Stage1-vs-Stage3 |
3.244200E-01 |
| Stage1-vs-Stage4 |
1.983620E-01 |
| Stage2-vs-Stage3 |
7.689800E-01 |
| Stage2-vs-Stage4 |
6.234200E-01 |
| Stage3-vs-Stage4 |
5.091800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.40149999886086E-08 |
| Normal-vs-AfricanAmerican |
7.143600E-03 |
| Normal-vs-Asian |
1.130220E-01 |
| Caucasian-vs-AfricanAmerican |
1.637650E-01 |
| Caucasian-vs-Asian |
4.297400E-01 |
| AfricanAmerican-vs-Asian |
9.096600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.24520002379114E-09 |
| Normal-vs-Female |
2.565900E-02 |
| Male-vs-Female |
7.177000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.061310E-03 |
| Normal-vs-Extreme_Weight |
2.61189999628542E-08 |
| Normal-vs-Obese |
1.476830E-03 |
| Normal-vs-Extreme_Obese |
1.238980E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.983800E-01 |
| Normal_Weight-vs-Obese |
3.618400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.458600E-01 |
| Extreme_Weight-vs-Obese |
2.738400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.723600E-01 |
| Obese-vs-Extreme_Obese |
3.917000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.453800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.62770999999617E-05 |
| Normal-vs-Age(61-80Yrs) |
1.96630000059983E-08 |
| Normal-vs-Age(81-100Yrs) |
7.86639999805772E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.819700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.795860E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.655150E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.661600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.542200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.869500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.14520004590446E-09 |
| Normal-VS-Type2 PRCC |
5.9381000000025E-05 |
| Normal-VS-KIRP CIMP |
1.190960E-01 |
| Normal-VS-Unclassified PRCC |
7.559900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.556000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.884600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.807400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.440400E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
8.606600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.827900E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.12259995638442E-09 |
| Normal-vs-N1 |
1.205980E-01 |
| Normal-vs-N2 |
7.334600E-01 |
| N0-vs-N1 |
1.959970E-03 |
| N0-vs-N2 |
4.510800E-01 |
| N1-vs-N2 |
9.169800E-01 |
|
|
